Cargando…
Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens
Mycoplasma gallisepticum (M. gallisepticum) is a primary respiratory pathogen of poultry and causes significant economic losses to the poultry industry. There were no reported articles concerning the Pharmacokinetics/Pharmacodynamics (PK/PD) interactions of tilmicosin against M. gallisepticum in viv...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557078/ https://www.ncbi.nlm.nih.gov/pubmed/36246335 http://dx.doi.org/10.3389/fvets.2022.952599 |
_version_ | 1784807221897461760 |
---|---|
author | Zhang, Nan Zhou, Minghu Yan, Xiu Liu, Jinxin Yuan, Sheng Yang, Hong Ding, Huanzhong Zhang, Dexian Bai, Yinshan |
author_facet | Zhang, Nan Zhou, Minghu Yan, Xiu Liu, Jinxin Yuan, Sheng Yang, Hong Ding, Huanzhong Zhang, Dexian Bai, Yinshan |
author_sort | Zhang, Nan |
collection | PubMed |
description | Mycoplasma gallisepticum (M. gallisepticum) is a primary respiratory pathogen of poultry and causes significant economic losses to the poultry industry. There were no reported articles concerning the Pharmacokinetics/Pharmacodynamics (PK/PD) interactions of tilmicosin against M. gallisepticum in vivo. In the current study, we established an in vivo M. gallisepticum infection model and tilmicosin was administered orally to the M. gallisepticum-infected chickens by different dosage regimens. The concentration of tilmicosin in lung tissue was determined by high-pressure liquid chromatography/tandem mass spectrometry (HPLC–MS/MS), besides the counting of the viable colony of M. gallisepticum in lung tissue was also monitored dynamically to appraise the PK/PD interactions of tilmicosin against M. gallisepticum. We found that anti-mycoplasmal activity was concentration-dependent and mycoplasmacidal activity was observed at tilmicosin dosage >7.5 mg/kg. The PK/PD parameter of AUC/MIC (The area under the concentration–time curve divided by the minimal inhibitory concentration) correlated well with anti-mycoplasmal efficacy (R(2) = 0.92). The ratios of AUC/MIC for 1 log(10) and 3 log(10) colony-forming units [CFU]/lung reductions were 300.02 and 6,950.15 h, respectively. These findings indicated that tilmicosin may be therapeutically effective in chickens to treat M. gallisepticum lung infections if administered at a dose of 9.12 mg/kg. |
format | Online Article Text |
id | pubmed-9557078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95570782022-10-14 Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens Zhang, Nan Zhou, Minghu Yan, Xiu Liu, Jinxin Yuan, Sheng Yang, Hong Ding, Huanzhong Zhang, Dexian Bai, Yinshan Front Vet Sci Veterinary Science Mycoplasma gallisepticum (M. gallisepticum) is a primary respiratory pathogen of poultry and causes significant economic losses to the poultry industry. There were no reported articles concerning the Pharmacokinetics/Pharmacodynamics (PK/PD) interactions of tilmicosin against M. gallisepticum in vivo. In the current study, we established an in vivo M. gallisepticum infection model and tilmicosin was administered orally to the M. gallisepticum-infected chickens by different dosage regimens. The concentration of tilmicosin in lung tissue was determined by high-pressure liquid chromatography/tandem mass spectrometry (HPLC–MS/MS), besides the counting of the viable colony of M. gallisepticum in lung tissue was also monitored dynamically to appraise the PK/PD interactions of tilmicosin against M. gallisepticum. We found that anti-mycoplasmal activity was concentration-dependent and mycoplasmacidal activity was observed at tilmicosin dosage >7.5 mg/kg. The PK/PD parameter of AUC/MIC (The area under the concentration–time curve divided by the minimal inhibitory concentration) correlated well with anti-mycoplasmal efficacy (R(2) = 0.92). The ratios of AUC/MIC for 1 log(10) and 3 log(10) colony-forming units [CFU]/lung reductions were 300.02 and 6,950.15 h, respectively. These findings indicated that tilmicosin may be therapeutically effective in chickens to treat M. gallisepticum lung infections if administered at a dose of 9.12 mg/kg. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9557078/ /pubmed/36246335 http://dx.doi.org/10.3389/fvets.2022.952599 Text en Copyright © 2022 Zhang, Zhou, Yan, Liu, Yuan, Yang, Ding, Zhang and Bai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Zhang, Nan Zhou, Minghu Yan, Xiu Liu, Jinxin Yuan, Sheng Yang, Hong Ding, Huanzhong Zhang, Dexian Bai, Yinshan Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title | Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title_full | Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title_fullStr | Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title_full_unstemmed | Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title_short | Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens |
title_sort | pharmacokinetic and pharmacodynamic integration of tilmicosin against mycoplasma gallisepticum in the target infection site in chickens |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557078/ https://www.ncbi.nlm.nih.gov/pubmed/36246335 http://dx.doi.org/10.3389/fvets.2022.952599 |
work_keys_str_mv | AT zhangnan pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT zhouminghu pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT yanxiu pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT liujinxin pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT yuansheng pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT yanghong pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT dinghuanzhong pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT zhangdexian pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens AT baiyinshan pharmacokineticandpharmacodynamicintegrationoftilmicosinagainstmycoplasmagallisepticuminthetargetinfectionsiteinchickens |